{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:24361865", "kind": "science-record", "revision": 6, "content_hash": "sha256:71f44c47536d83ba0364d1d4e1a4ffeaf0fefa419226c125bb6b0776b3f60d70", "created_at": "2026-11-01T15:40:04Z", "updated_at": "2026-11-01T21:19:45Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.", "doi": "10.1074/mcp.M113.030775", "pmid": "24361865", "authors": ["Filip Mundt", "Henrik J Johansson", "Jenny Forshed", "Sertaç Arslan", "Muzaffer Metintas", "Katalin Dobra", "Janne Lehtiö", "Anders Hjerpe"], "journal": "Molecular & cellular proteomics : MCP", "year": 2014, "abstract": "Malignant mesothelioma is an aggressive asbestos-induced cancer, and affected patients have a median survival of approximately one year after diagnosis. It is often difficult to reach a conclusive diagnosis, and ancillary measurements of soluble biomarkers could increase diagnostic accuracy. Unfortunately, few soluble mesothelioma biomarkers are suitable for clinical application. Here we screened the effusion proteomes of mesothelioma and lung adenocarcinoma patients to identify novel soluble mesothelioma biomarkers. We performed quantitative mass-spectrometry-based proteomics using isobaric tags for quantification and used narrow-range immobilized pH gradient/high-resolution isoelectric focusing (pH 4-4.25) prior to analysis by means of nano liquid chromatography coupled to MS/MS. More than 1,300 proteins were identified in pleural effusions from patients with malignant mesothelioma (n = 6), lung adenocarcinoma (n = 6), or benign mesotheliosis (n = 7). Data are available via ProteomeXchange with identifier PXD000531. The identified proteins included a set of known mesothelioma markers and proteins that regulate hallmarks of cancer such as invasion, angiogenesis, and immune evasion, plus several new candidate proteins. Seven candidates (aldo-keto reductase 1B10, apolipoprotein C-I, galectin 1, myosin-VIIb, superoxide dismutase 2, tenascin C, and thrombospondin 1) were validated by enzyme-linked immunosorbent assays in a larger group of patients with mesothelioma (n = 37) or metastatic carcinomas (n = 25) and in effusions from patients with benign, reactive conditions (n = 16). Galectin 1 was identified as overexpressed in effusions from lung adenocarcinoma relative to mesothelioma and was validated as an excellent predictor for metastatic carcinomas against malignant mesothelioma. Galectin 1, aldo-keto reductase 1B10, and apolipoprotein C-I were all identified as potential prognostic biomarkers for malignant mesothelioma. This analysis of the effusion proteome furthers our understanding of malignant mesothelioma, identified galectin 1 as a potential diagnostic biomarker, and highlighted several possible prognostic biomarkers of this disease.", "claims": [{"id": "claim-method", "statement": "The three sample groups (mesothelioma, metastatic carcinomas, and benign conditions) were compared using the nonparametric Kruskal–Wallis test, with comparisons between groups performed using Dunn's post hoc test to obtain multiplicity-adjusted p values.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:24361865", "locator": "sections[26] \"Comparison of Groups Using One-way ANOVA\" paragraph 2", "quote": "The three sample groups (mesothelioma, metastatic carcinomas, and benign conditions) were compared using the nonparametric Kruskal–Wallis test, with comparisons between groups performed using Dunn's post hoc test to obtain multiplicity-adjusted p values."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The raw data associated with this manuscript have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository (36) with the dataset identifier PXD000531.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:24361865", "locator": "sections[18] \"Peptide and Protein Identification\" paragraph 2", "quote": "The raw data associated with this manuscript have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository (36) with the dataset identifier PXD000531."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Cutoff Finder–selected, Kaplan–Meier survival analysis with log-rank testing found significant prognostic trends for aldo-keto reductase 1B10, apolipoprotein C-I, and galectin 1 in malignant mesothelioma (hazard ratios 3.4, 2.30, and 2.34, respectively), while the proteomics source data were deposited through ProteomeXchange under identifier PXD000531.", "kind": "quantitative", "target": {"value": 95.0, "unit": "per cent", "tolerance": null, "source": "For aldo-keto reductase 1B10, there was a survival difference of 5.5 months for patients below and above 0.65 ng/ml (11- and 5.5-month median survival, respectively; p value = 0.01), and the corresponding Mantel–Cox hazard ratio was 3.4 between the two groups (95% confidence interval = 1.33–8.63)."}, "evidence": [{"asset": "source:pmid:24361865", "locator": "sections[28] \"Survival Analysis\" paragraph 2", "quote": "The Web-based threshold selection tool Cutoff Finder was used to condition a threshold for each biomarker based on its most significant hazard ratio (42)."}, {"asset": "source:pmid:24361865", "locator": "sections[28] \"Survival Analysis\" paragraph 2", "quote": "The Kaplan–Meier estimator was used to evaluate possible prognostic information."}, {"asset": "source:pmid:24361865", "locator": "sections[28] \"Survival Analysis\" paragraph 2", "quote": "The log-rank (Mantel–Cox) test was performed to compare survival curves and to estimate hazard ratios."}, {"asset": "source:pmid:24361865", "locator": "sections[40] \"Survival Analyses\" paragraph 2", "quote": "Aldo-keto reductase 1B10, apolipoprotein C-I, and galectin 1 showed significant prognostic trends (Fig. 6)."}, {"asset": "source:pmid:24361865", "locator": "sections[40] \"Survival Analyses\" paragraph 2", "quote": "For aldo-keto reductase 1B10, there was a survival difference of 5.5 months for patients below and above 0.65 ng/ml (11- and 5.5-month median survival, respectively; p value = 0.01), and the corresponding Mantel–Cox hazard ratio was 3.4 between the two groups (95% confidence interval = 1.33–8.63)."}, {"asset": "source:pmid:24361865", "locator": "sections[40] \"Survival Analyses\" paragraph 2", "quote": "Patients with high apolipoprotein C-I levels (>5.33 μg/ml) also had a mean survival time that was 5.5 months longer (10 months compared with low expressing patients' survival of 4.5 months; p value = 0.02) with a reciprocal hazard ratio of 2.30 (1.4–9.0)."}, {"asset": "source:pmid:24361865", "locator": "sections[40] \"Survival Analyses\" paragraph 2", "quote": "At a cutoff of 22.5 ng/ml, galectin 1 separated high- and low-expressing patients with median survival times of 4.5 and 9.5 months, respectively (p value = 0.04), with a hazard ratio of 2.34 (1.02–5.41)."}, {"asset": "source:pmid:24361865", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Data are available via ProteomeXchange with identifier PXD000531."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "Cutoff Finder–selected, Kaplan–Meier survival analysis with log-rank testing found significant prognostic trends for aldo-keto reductase 1B10, apolipoprotein C-I, and galectin 1 in malignant mesothelioma (hazard ratios 3.4, 2.30, and 2.34, respectively), while the proteomics source data were deposited through ProteomeXchange under identifier PXD000531.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:24361865"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD000531"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD000531"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:24361865", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1074/mcp.M113.030775", "sha256": "sha256:f1c3e5afff3de429f29482657a3ff601b556e475894574baa94cf2dd76158cb9", "bytes": 48636, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1074/mcp.M113.030775", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC3945903", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD000531", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD000531", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD000531", "version": null, "note": "The raw data associated with this manuscript have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository (36) with the dataset identifier PXD000531.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The raw data associated with this manuscript have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository (36) with the dataset identifier PXD000531.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Human pleural effusion LC-MSMS", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:24361865:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:66ae17382364868ad904c366eac999716d94c8318eaf512cc43385c8524a5956", "bytes": 1050, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#TI", "version": null, "note": "Characteristics of the discovery population: patients screened by mass-spectrometry-based quantitative proteomics", "structure": {"pmcid": "PMC3945903", "section_index": 10, "section_title": "Discovery Population", "row_count": 23, "column_count": 4}, "table": {"label": "Table I", "caption": "Characteristics of the discovery population: patients screened by mass-spectrometry-based quantitative proteomics", "rows": [["Patients screened with mass spectrometry", "Age (yr)", "Gender", "Comorbidities"], ["Mesotheliomas (n = 6)", "Median = 65.5", "", ""], ["Epithelioid", "70", "Male", ""], ["Epithelioid", "65", "Male", "HT, CHF"], ["Epithelioid", "55", "Male", ""], ["Epithelioid", "66", "Male", ""], ["Epithelioid", "53", "Male", ""], ["Epithelioid", "75", "Male", "BPH"], ["Adenocarcinomas (n = 6)", "Median = 72.5", "", ""], ["Lung", "77", "Male", "CAD, HT, COPD, ICH"], ["Lung", "77", "Male", ""], ["Lung", "62", "Male", ""], ["Lung", "73", "Male", ""], ["Lung", "58", "Male", ""], ["Lung", "72", "Male", "HT, BPH, COPD"], ["Benign pleurisies (n = 7)", "Median = 81", "", ""], ["Pool 1", "66", "Female", ""], ["Pool 1", "94", "Female", ""], ["Pool 1", "89", "Female", ""], ["Pool 2", "55", "Male", ""], ["Pool 2", "70", "Male", ""], ["Pool 2", "81", "Male", ""], ["Pool 2", "81", "Male", ""]], "row_count": 23, "column_count": 4, "numeric_cells": 32, "header_rows": 1, "locator": "section[10]/table-wrap[1]#TI"}}, {"id": "asset:table:pmid:24361865:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:feef568878fb6267e9dd38a2ec33ea54566c064053150608eaba56ec8a7f6824", "bytes": 453, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#TII", "version": null, "note": "Characteristics of the validation population", "structure": {"pmcid": "PMC3945903", "section_index": 11, "section_title": "Validation Population", "row_count": 14, "column_count": 2}, "table": {"label": "Table II", "caption": "Characteristics of the validation population", "rows": [["Validation population", "n"], ["Mesothelioma", "37"], ["Epithelioid", "30"], ["Biphasic", "5"], ["Sarcomatoid", "2"], ["Metastatic carcinomas", "25"], ["Lung", "20"], ["Breast", "4"], ["Kidney", "1"], ["Benign diseases", "16"], ["BAP", "9"], ["PPP", "3"], ["TBC", "2"], ["CHF", "2"]], "row_count": 14, "column_count": 2, "numeric_cells": 13, "header_rows": 1, "locator": "section[11]/table-wrap[1]#TII"}}, {"id": "asset:table:pmid:24361865:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:3789c669ba3f375642f56eed401dd5c68aa6a1c2465f9c7ca1c377798d66a7fd", "bytes": 1139, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[37]/table-wrap[1]#TIV", "version": null, "note": "List of the proteins identified and quantified in the significant analysis of microarrays", "structure": {"pmcid": "PMC3945903", "section_index": 21, "section_title": "Univariate Analysis", "row_count": 22, "column_count": 3}, "table": {"label": "Table IV", "caption": "List of the proteins identified and quantified in the significant analysis of microarrays", "rows": [["Protein name", "FC", "q-value"], ["Myosin-VIIb", "4.5", "0"], ["Superoxide dismutase 2a", "4.1", "0"], ["Keratin, type II cytoskeletal 8", "3.1", "0"], ["Thrombospondin 1", "2.7", "0"], ["AF4/FMR2 family, member 3", "2.9", "20.2"], ["Apolipoprotein C-Ia", "2.5", "20.2"], ["Fructose-bisphosphate aldolase A", "2.4", "20.2"], ["Tenascin C", "2.3", "20.2"], ["Collagen α-1(VI) chain", "2.1", "20.2"], ["Conserved oligomeric Golgi complex subunit 3", "2.7", "34.6"], ["Keratin 81", "2.6", "34.6"], ["Versican core protein", "2.6", "34.6"], ["Negative elongation factor B", "2.6", "34.6"], ["Aldo-keto reductase family 1 member B10", "2.4", "34.6"], ["Osteopontina", "2.3", "34.6"], ["ATP synthase subunit α", "2.3", "34.6"], ["Splicing factor, arginine/serine-rich 3", "2.2", "34.6"], ["Lamin B1", "2.0", "34.6"], ["Niemann-Pick disease, type C2", "1.9", "34.6"], ["Coiled-coil domain containing 91", "1.9", "34.6"], ["Actin, α cardiac muscle 1", "1.6", "34.6"]], "row_count": 22, "column_count": 3, "numeric_cells": 53, "header_rows": 1, "locator": "section[37]/table-wrap[1]#TIV"}}, {"id": "asset:table:pmid:24361865:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4de26f05f23eb67afa6e8c87cec72878b12d180c2224f1b7c58d4bfc13546a6d", "bytes": 2573, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[36]/table-wrap[1]#TIII", "version": null, "note": "Proteins included in the optimized OPLS-DA model", "structure": {"pmcid": "PMC3945903", "section_index": 36, "section_title": "Multivariate Analysis—Supervised OPLS-DA", "row_count": 38, "column_count": 5}, "table": {"label": "Table III", "caption": "Proteins included in the optimized OPLS-DA model", "rows": [["Gene name", "UniProt entry", "Protein name", "FC", "q-value"], ["SOD2", "P04179", "Superoxide dismutase [Mn], mitochondrial", "4.1", "0.0"], ["AFF3", "P51826", "AF4/FMR2 family, member 3", "2.8", "20.2"], ["THBS1", "P07996", "Thrombospondin-1", "2.4", "0.0"], ["ATP5A1", "P25705", "ATP synthase subunit α", "2.3", "34.6"], ["COL6A1", "P12109", "Collagen, type VI, α 1", "2.1", "20.2"], ["RPL21", "P46778", "60S ribosomal protein L21", "1.8", "40.4"], ["RAB1B", "E9PLD0", "Ras-related protein Rab-1B", "1.7", "45.8"], ["SEPT10", "Q9P0V9", "Septin 10", "−1.1", "76.4"], ["C8B", "P07358", "Complement component C8 β chain", "−1.1", "76.5"], ["DSG2", "Q14126", "Desmoglein-2", "−1.2", "67.6"], ["KNTC1", "P50748", "Kinetochore-associated protein 1", "−1.3", "66.4"], ["TUBA1B", "P68363", "Tubulin α-1B chain", "−1.3", "68.9"], ["HGFAC", "Q04756", "Hepatocyte growth factor activator", "−1.4", "66.4"], ["ICAM1", "P05362", "Intercellular adhesion molecule 1", "−1.5", "65.1"], ["CP", "P00450", "Ceruloplasmin", "−1.5", "65.1"], ["KRT71", "Q3SY84", "Keratin, type II cytoskeletal 71", "−1.5", "65.1"], ["ZNF704", "Q6ZNC4", "Zinc finger protein 704", "−1.5", "65.1"], ["C8G", "P07360", "Complement component C8 γ chain", "−1.5", "64.1"], ["ZNF670", "Q9BS34", "Zinc finger protein 670", "−1.5", "67.6"], ["C9", "P02748", "Complement component C9", "−1.6", "64.1"], ["C1S", "P09871", "Complement component 1, s subcomponent", "−1.6", "64.1"], ["COL3A1", "P02461", "Collagen α-1(III) chain", "−1.6", "65.1"], ["GOLM1", "Q8NBJ4", "Golgi membrane protein 1", "−1.7", "64.1"], ["C16orf71", "Q8IYS4", "Uncharacterized protein C16orf71", "−1.7", "65.1"], ["SDC1", "P18827", "Syndecan-1", "−1.8", "64.1"], ["NRP1", "O14786", "Neuropilin 1", "−1.8", "64.1"], ["HRG", "P04196", "Histidine-rich glycoprotein", "−1.8", "64.1"], ["F12", "P00748", "Coagulation factor XII", "−1.9", "64.1"], ["LRRC28", "Q86X40", "Leucine-rich repeat-containing protein 28", "−2.0", "64.1"], ["SERPINA4", "P29622", "Kallistatin (KAL)", "−2.0", "64.1"], ["LRG1", "P02750", "Leucine-rich α-2-glycoprotein", "−2.1", "64.1"], ["MMRN2", "Q9H8L6", "Multimerin 2", "−2.3", "64.1"], ["POU4F3", "Q15319", "POU domain, class 4, transcription factor 3", "−2.3", "64.1"], ["LAMA4", "Q16363", "Laminin, α 4", "−2.5", "64.1"], ["FBF1", "Q8TES7", "Fas binding factor 1", "−2.5", "64.1"], ["FXYD3", "Q14802", "FXYD domain-containing ion transport regulator 3", "−2.6", "64.1"], ["C4BPA", "P04003", "C4b-binding protein α chain", "−3.0", "64.1"]], "row_count": 38, "column_count": 5, "numeric_cells": 138, "header_rows": 1, "locator": "section[36]/table-wrap[1]#TIII"}}, {"id": "asset:table:pmid:24361865:5", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:3789c669ba3f375642f56eed401dd5c68aa6a1c2465f9c7ca1c377798d66a7fd", "bytes": 1139, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[37]/table-wrap[1]#TIV", "version": null, "note": "List of the proteins identified and quantified in the significant analysis of microarrays", "structure": {"pmcid": "PMC3945903", "section_index": 37, "section_title": "Univariate Analysis", "row_count": 22, "column_count": 3}, "table": {"label": "Table IV", "caption": "List of the proteins identified and quantified in the significant analysis of microarrays", "rows": [["Protein name", "FC", "q-value"], ["Myosin-VIIb", "4.5", "0"], ["Superoxide dismutase 2a", "4.1", "0"], ["Keratin, type II cytoskeletal 8", "3.1", "0"], ["Thrombospondin 1", "2.7", "0"], ["AF4/FMR2 family, member 3", "2.9", "20.2"], ["Apolipoprotein C-Ia", "2.5", "20.2"], ["Fructose-bisphosphate aldolase A", "2.4", "20.2"], ["Tenascin C", "2.3", "20.2"], ["Collagen α-1(VI) chain", "2.1", "20.2"], ["Conserved oligomeric Golgi complex subunit 3", "2.7", "34.6"], ["Keratin 81", "2.6", "34.6"], ["Versican core protein", "2.6", "34.6"], ["Negative elongation factor B", "2.6", "34.6"], ["Aldo-keto reductase family 1 member B10", "2.4", "34.6"], ["Osteopontina", "2.3", "34.6"], ["ATP synthase subunit α", "2.3", "34.6"], ["Splicing factor, arginine/serine-rich 3", "2.2", "34.6"], ["Lamin B1", "2.0", "34.6"], ["Niemann-Pick disease, type C2", "1.9", "34.6"], ["Coiled-coil domain containing 91", "1.9", "34.6"], ["Actin, α cardiac muscle 1", "1.6", "34.6"]], "row_count": 22, "column_count": 3, "numeric_cells": 53, "header_rows": 1, "locator": "section[37]/table-wrap[1]#TIV"}}, {"id": "asset:table:pmid:24361865:6", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f5c7f175845989e1dc5eb310764a525632ad6d0629f5eb43ab0173ff0bd55890", "bytes": 843, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[39]/table-wrap[1]#TV", "version": null, "note": "Receiver operator characteristic curves for validated candidates", "structure": {"pmcid": "PMC3945903", "section_index": 39, "section_title": "Validation of Biomarker Candidate Proteins in an Extended Patient Group", "row_count": 11, "column_count": 3}, "table": {"label": "Table V", "caption": "Receiver operator characteristic curves for validated candidates", "rows": [["Biomarker candidate", "AUC (95%CI)"], ["MM vs. non-MM", "MM vs. Mets"], ["Aldo-keto reductase 1B10", "0.71 (0.59–0.83)", "0.66 (0.52–0.81)"], ["Apolipoprotein C-I", "0.60 (0.46–0.73)", "0.57 (0.41–0.74)"], ["Galectin 1", "0.87 (0.79–0.95)", "0.93 (0.86–0.99)"], ["Myosin-VIIb", "0.60 (0.47–0.74)", "0.59 (0.43–0.75)"], ["Superoxide dismutase 2", "0.64 (0.51–0.78)", "0.71 (0.55–0.86)"], ["Tenascin C", "0.54 (0.40–0.68)", "0.56 (0.40–0.72)"], ["Thrombospondin 1", "0.54 (0.40–0.68)", "0.54 (0.37–0.70)"], ["Hyaluronan", "0.71 (0.59–0.83)", "0.82 (0.70–0.94)"], ["N-ERC/mesothelin", "0.89 (0.80–0.97)", "0.87 (0.77–0.96)"]], "row_count": 11, "column_count": 3, "numeric_cells": 23, "header_rows": 2, "locator": "section[39]/table-wrap[1]#TV"}}], "gaps": ["asset:data:geo:PXD000531 not downloaded", "asset:data:geo:PXD000531 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "Nonparametric Kruskal–Wallis test with Dunn’s post hoc test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The three sample groups (mesothelioma, metastatic carcinomas, and benign conditions) were compared using the nonparametric Kruskal–Wallis test, with comparisons between groups performed using Dunn's post hoc test to obtain multiplicity-adjusted p values."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": null, "expected_value": 95.0, "unit": "per cent", "tolerance": null, "state": "complete", "note": "The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none."}], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (Nonparametric Kruskal–Wallis test with Dunn’s post hoc test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD000531"], "resolved_accessions": ["PXD000531"], "statements": ["The raw data associated with this manuscript have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository (36) with the dataset identifier PXD000531."], "basis": "The paper names PXD000531 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:24361865", "data:geo:PXD000531", "asset:table:pmid:24361865:1", "asset:table:pmid:24361865:2", "asset:table:pmid:24361865:3", "asset:table:pmid:24361865:4", "asset:table:pmid:24361865:5", "asset:table:pmid:24361865:6"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD000531"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:22:00Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 93434, "completion_tokens": 3682, "cached_tokens": 81340}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:24361865", "type": "paper", "label": "pmid:24361865"}, {"id": "source:pmid:24361865", "type": "manuscript", "label": "PMID 24361865 full text"}, {"id": "data:geo:PXD000531", "type": "dataset", "label": "GEO PXD000531"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:24361865", "type": "paper", "label": "pmid:24361865"}, {"id": "source:pmid:24361865", "type": "manuscript", "label": "PMID 24361865 full text"}, {"id": "data:geo:PXD000531", "type": "dataset", "label": "GEO PXD000531"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-24361865", "type": "extraction", "used": ["source:pmid:24361865"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD000531", "type": "accession_resolution", "used": ["data:geo:PXD000531"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:24361865", "parent_hash": "sha256:dc7e553e088cb2322062fcc6b649a4af0975b47bc35d3e913c8f904c197f43d4", "fork_of": null, "generation": 5}, "gaps": ["asset:data:geo:PXD000531 licence not read", "asset:data:geo:PXD000531 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.69, "evidence": ["rformed quantitative mass-spectrometry-based proteomics using isobaric tags for quantification and u"], "order_basis": "paper_text_order:689", "id": "assay:1"}, {"role": "data_generation", "definition_id": "elisa", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["d suggested biological relevance. Commercial ELISA assays were used to analyze samples from an", "validation population as measured by MS and ELISA, respectively. Receiver operator characteris", ". Mass-spectrometry-based quantification and ELISA-based validation of selected candidate bioma", "standard error of the mean are indicated for ELISA results. Other t tests did not result in p v"], "order_basis": "paper_text_order:3939", "id": "assay:2"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T02:45:50+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}